Moody's Corporation

▲ Bull Case

• ◆Private credit ratings become a $1B+ MIS revenue line: AUM reaches $5T by 2030; institutional mandates require external ratings; 400+ deals/quarter generates $750M–1B incremental MIS revenue by FY2028; consensus models have $0–100M; the surprise is magnitude and pace.
• ◆MA achieves SPGI-level multiple: MA reaches 44–45% of MCO revenue by FY2028 (growing 10%/yr); institutional recognition of MA as mission-critical recurring platform drives P/E from 30x to 38x; adds ~$75–100/share independent of earnings growth.
• ◆EPS compounds above 15%/yr through FY2028: Private credit (new TAM) + MA compounding + MIS maturity wall + 2–2.5%/yr buyback = adj EPS $25.00 by FY2028; at 37x = $925 (+87%).

▼ Bear Case

• ◆MIS issuance trough (mild recession): I-G issuance falls 15–20% in 2026–2027 recession; MIS revenue falls to $4B–4.3B (from $4.71B); operating margin compresses 400–500bps; adj EPS $13.00 FY2028; multiple compresses to 24x; stock falls to $312 (–37%).
• ◆MA growth decelerates: Financial institution customers cut tech spending in recession; MA growth falls from 9% to 5–6%; Decision Solutions KYC contracts cancelled or deferred; MA margin compresses; EPS double-hit (MIS cyclical + MA slowdown).
• ◆P/E multiple contracts structurally: Interest rates stay elevated (10yr UST 5%+); high-multiple growth stocks de-rate across the board; MCO's P/E compresses from 30x to 22–24x even with continued earnings growth; stock goes nowhere for 2–3 years despite +10%/yr EPS.

“The central debate: Is MCO's current 30x FY2026E P/E justified by private credit TAM optionality, or is the market already pricing it in? Bull view: Private credit is NOT priced in; consensus models have minimal contribution; Q1 2025's +107% deal growth is newly reported and undermodeled; $2T→$5T AUM trajectory means private credit becomes dominant MIS growth driver by FY2027–2028, driving EPS $2–4/share above consensus by FY2028. Bear view: The maturity wall and private credit TAM are market-known; $495 at 30x already prices MIS recovery; if the cycle turns down, all optionality disappears. Our view: Private credit is partially priced but not fully; TAM magnitude underestimated; at $495 risk/reward is balanced (not cheap enough to strongly buy, but quality high enough to HOLD); entry below $450 adds margin of safety making private credit optionality 'free.'”

• ◆Private credit deal disclosures: 200+ deals/quarter in FY2026 validates $500M–1B TAM expansion thesis (currently 143 deals/quarter, +107% YoY).
• ◆MA segment reaches 42%+ of total revenue: Signals successful diversification; expected FY2026–Q4; drives re-rating toward SPGI's 38–42x multiple.
• ◆Corporate maturity wall drives MIS beats: $2.5–3T corporate debt matures through 2027; refinancing mandatory; MIS revenue above-trend Q2–Q3 2026; EPS guidance raise target >$17.00 midpoint.
• ◆Macro-driven de-rating below $450: Recession, Fed pivot, or issuance trough creates entry opportunity with 2.0x+ risk/reward potential.

• ◆MIS issuance cycle trough (20% probability): Mild recession triggers 15–20% drop in I-G issuance; MIS revenue falls to $4B–4.3B; operating margin compresses 400–500bps; EPS trough $13.00 FY2028; stock falls to $312 (–37%). Mitigant: MCO survived 2022 (–35% revenue trough) and recovered sharply; EPS doubled in 3 years.
• ◆Regulatory disruption to issuer-pays model (5% probability): Congressional legislation restructuring rating agency revenue model would be existential threat. Low probability given Basel III mandate and failed reform attempts since 2008, but would be kill-switch if political winds shift.
• ◆MA growth deceleration (15% probability): Financial institution customers cut tech spending in recession; MA growth falls below 5%; Decision Solutions KYC contracts deferred; segment margin compresses; EPS double-hit changes thesis from stable compounder to pure cyclical.
• ◆Competitive pressure on oligopoly (5% probability): AI-assisted credit analysis or new entrant challenge. Mitigated by 70+ years of credit performance data (irreplaceable) and regulatory NRSRO barrier (10–15 years to achieve equivalent recognition).